Skip Navigation

European Heart Journal 1992 13(Supplement D):66-69; doi:10.1093/eurheartj/13.suppl_D.66
Copyright © 1992 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Grodzicki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Grodzicki, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 The European Society of Cardiology

Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death

F. H. Messerli and T. Grodzicki

Department of Internal Medicine, Section on Hypertension, Ochsner Clinic and Alton Ochsner Medical Foundation New Orleans, Louisiana, U.S.A.

Address for correspondence: Dr Messerli, Ochsner Clinic 1514 Jefferson Highway, New Orleans, Louisiana 70121, U.S.A.

LVH is a common sequela of arterial hypertension; it increases the risk of sudden death and other cardiovascular morbidity and mortality independent of arterial pressure and has been asociated with ventricular arrhythmias. Electro-physiological studies suggest a connection between ventricular arrhythmias in patients with LVH and sudden death. LVH can be reduced by specific antihyper tensive therapy, although not all drugs are equipolent in this regard A reduction in LVH has been shown to diminish ventricular ectopy. Preliminary findings suggest that a reduction of LVH and associated arrhythmias may reduce its inherent cardiovascular risk.

Key Words: Hypertension • left ventricular hypertrophy • ventricular arrhythmias • sudden death • antihypertensive therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. Peschar, K. Vernooy, W. Y.R Vanagt, R. S Reneman, M. A Vos, and F. W Prinzen
Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles
Cardiovasc Res, June 1, 2003; 58(3): 510 - 517.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
A Yildirir, M. K Batur, and A Oto
Hypertension and arrhythmia: blood pressure control and beyond
Europace, January 1, 2002; 4(2): 175 - 182.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
Eur. Heart J., October 2, 2000; 21(20): 1653 - 1665.
[PDF]

Home page
 Cardiovasc ResHome page
G. R. Dalton, J. V. Jones, S. J. Evans, and A. J. Levi
Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment
Cardiovasc Res, March 1, 1997; 33(3): 561 - 572.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.